Literature DB >> 24154626

Programmed death 1-mediated T cell exhaustion during visceral leishmaniasis impairs phagocyte function.

Kevin J Esch1, Rachel Juelsgaard, Pedro A Martinez, Douglas E Jones, Christine A Petersen.   

Abstract

Control of Leishmania infantum infection is dependent upon Th1 CD4(+) T cells to promote macrophage intracellular clearance of parasites. Deficient CD4(+) T cell effector responses during clinical visceral leishmaniasis (VL) are associated with elevated production of IL-10. In the primary domestic reservoir of VL, dogs, we define occurrence of both CD4(+) and CD8(+) T cell exhaustion as a significant stepwise loss of Ag-specific proliferation and IFN-γ production, corresponding to increasing VL symptoms. Exhaustion was associated with a 4-fold increase in the population of T cells with surface expression of programmed death 1 (PD-1) between control and symptomatic populations. Importantly, exhausted populations of CD8(+) T cells and to a lesser extent CD4(+) T cells were present prior to onset of clinical VL. VL-exhausted T cells did not undergo significant apoptosis ex vivo after Ag stimulation. Ab block of PD-1 ligand, B7.H1, promoted return of CD4(+) and CD8(+) T cell function and dramatically increased reactive oxygen species production in cocultured monocyte-derived phagocytes. As a result, these phagocytes had decreased parasite load. To our knowledge, we demonstrate for the first time that pan-T cell, PD-1-mediated, exhaustion during VL influenced macrophage-reactive oxygen intermediate production. Blockade of the PD-1 pathway improved the ability of phagocytes isolated from dogs presenting with clinical VL to clear intracellular parasites. T cell exhaustion during symptomatic canine leishmaniasis has implications for the response to vaccination and therapeutic strategies for control of Leishmania infantum in this important reservoir species.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24154626      PMCID: PMC3896087          DOI: 10.4049/jimmunol.1301810

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

1.  Antigen-specific CD4 T-cell help rescues exhausted CD8 T cells during chronic viral infection.

Authors:  Rachael D Aubert; Alice O Kamphorst; Surojit Sarkar; Vaiva Vezys; Sang-Jun Ha; Daniel L Barber; Lilin Ye; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

Review 2.  Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?

Authors:  François Chappuis; Shyam Sundar; Asrat Hailu; Hashim Ghalib; Suman Rijal; Rosanna W Peeling; Jorge Alvar; Marleen Boelaert
Journal:  Nat Rev Microbiol       Date:  2007-11       Impact factor: 60.633

3.  Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection.

Authors:  Elias A Said; Franck P Dupuy; Lydie Trautmann; Yuwei Zhang; Yu Shi; Mohamed El-Far; Brenna J Hill; Alessandra Noto; Petronela Ancuta; Yoav Peretz; Simone G Fonseca; Julien Van Grevenynghe; Mohamed R Boulassel; Julie Bruneau; Naglaa H Shoukry; Jean-Pierre Routy; Daniel C Douek; Elias K Haddad; Rafick-Pierre Sekaly
Journal:  Nat Med       Date:  2010-03-07       Impact factor: 53.440

Review 4.  T cell exhaustion.

Authors:  E John Wherry
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

Review 5.  Leishmaniasis: complexity at the host-pathogen interface.

Authors:  Paul Kaye; Phillip Scott
Journal:  Nat Rev Microbiol       Date:  2011-07-11       Impact factor: 60.633

6.  The TGF-beta response to Leishmania chagasi in the absence of IL-12.

Authors:  Mary E Wilson; Thomas J Recker; Nilda E Rodriguez; Betty M Young; Kindra K Burnell; Judy A Streit; Joel N Kline
Journal:  Eur J Immunol       Date:  2002-12       Impact factor: 5.532

7.  Leishmania GP63 alters host signaling through cleavage-activated protein tyrosine phosphatases.

Authors:  Maria Adelaida Gomez; Irazu Contreras; Maxime Hallé; Michel L Tremblay; Robert W McMaster; Martin Olivier
Journal:  Sci Signal       Date:  2009-09-29       Impact factor: 8.192

8.  Viral immune evasion due to persistence of activated T cells without effector function.

Authors:  A J Zajac; J N Blattman; K Murali-Krishna; D J Sourdive; M Suresh; J D Altman; R Ahmed
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

9.  B7-H1 blockade increases survival of dysfunctional CD8(+) T cells and confers protection against Leishmania donovani infections.

Authors:  Trupti Joshi; Susana Rodriguez; Vladimir Perovic; Ian A Cockburn; Simona Stäger
Journal:  PLoS Pathog       Date:  2009-05-15       Impact factor: 6.823

10.  Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani.

Authors:  H W Murray; C F Nathan
Journal:  J Exp Med       Date:  1999-02-15       Impact factor: 14.307

View more
  75 in total

1.  Myeloid-derived suppressor cells impair alveolar macrophages through PD-1 receptor ligation during Pneumocystis pneumonia.

Authors:  Guang-Sheng Lei; Chen Zhang; Chao-Hung Lee
Journal:  Infect Immun       Date:  2014-11-17       Impact factor: 3.441

2.  Safety Analysis of Leishmania Vaccine Used in a Randomized Canine Vaccine/Immunotherapy Trial.

Authors:  Angela Toepp; Mandy Larson; Tara Grinnage-Pulley; Carolyne Bennett; Michael Anderson; Molly Parrish; Hailie Fowler; Geneva Wilson; Katherine Gibson-Corely; Radhika Gharpure; Caitlin Cotter; Christine Petersen
Journal:  Am J Trop Med Hyg       Date:  2018-03-01       Impact factor: 2.345

3.  PTPN22 contributes to exhaustion of T lymphocytes during chronic viral infection.

Authors:  Christian J Maine; John R Teijaro; Kristi Marquardt; Linda A Sherman
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-31       Impact factor: 11.205

4.  Semi-quantitative measurement of asymptomatic L. infantum infection and symptomatic visceral leishmaniasis in dogs using Dual-Path Platform® CVL.

Authors:  Mandy Larson; Angela Toepp; Benjamin Scott; Melissa Kurtz; Hailie Fowler; Javan Esfandiari; Randall F Howard; Aarthy C Vallur; Malcolm S Duthie; Christine Petersen
Journal:  Appl Microbiol Biotechnol       Date:  2016-10-31       Impact factor: 4.813

Review 5.  T cell costimulation, checkpoint inhibitors and anti-tumor therapy.

Authors:  Dipankar Nandi; Sanmoy Pathak; Taru Verma; Madhulika Singh; Avik Chattopadhyay; Samriddhi Thakur; Abinaya Raghavan; Abhijeet Gokhroo
Journal:  J Biosci       Date:  2020       Impact factor: 1.826

6.  Decreased PD-1/PD-L1 Expression Is Associated with the Reduction in Mucosal Immunoglobulin A in Mice with Intestinal Ischemia Reperfusion.

Authors:  Xu-Yu Zhang; Zi-Meng Liu; Hu-Fei Zhang; Yun-Sheng Li; Shi-Hong Wen; Jian-Tong Shen; Ke-Xuan Liu
Journal:  Dig Dis Sci       Date:  2015-05-06       Impact factor: 3.199

7.  Leishmania-Derived Trimannose Modulates the Inflammatory Response To Significantly Reduce Leishmania major-Induced Lesions.

Authors:  Tara L Grinnage-Pulley; Daniel E K Kabotso; Chelsea L Rintelmann; Rajarshi Roychoudhury; Robert G Schaut; Angela J Toepp; Katherine N Gibson-Corley; Molly Parrish; Nicola L B Pohl; Christine A Petersen
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

8.  Recovery of antigen-specific T cell responses from dogs infected with Leishmania (L.) infantum by use of vaccine associated TLR-agonist adjuvant.

Authors:  Robert G Schaut; Tara L Grinnage-Pulley; Kevin J Esch; Angela J Toepp; Malcolm S Duthie; Randall F Howard; Steven G Reed; Christine A Petersen
Journal:  Vaccine       Date:  2016-09-21       Impact factor: 3.641

Review 9.  Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease.

Authors:  John Attanasio; E John Wherry
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

10.  CD8+ T cell exhaustion, suppressed gamma interferon production, and delayed memory response induced by chronic Brucella melitensis infection.

Authors:  Marina Durward-Diioia; Jerome Harms; Mike Khan; Cherisse Hall; Judith A Smith; Gary A Splitter
Journal:  Infect Immun       Date:  2015-09-28       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.